Results 31 to 40 of about 18,733 (258)
The use of pure and impure placebo interventions in primary care - a qualitative approach
Background Placebos play an important role in clinical trials and several surveys have shown that they are also common in daily practice. Previous research focused primarily on the frequency of placebo use in outpatient care.
Senn Oliver +4 more
doaj +1 more source
Placebo Trends across the Border: US versus Canada. [PDF]
Physicians around the world report to using placebos in a variety of situations and with varying degrees of frequency. Inconsistent methodologies, however, complicate interpretation and prevent direct comparisons across studies.
Cory S Harris +2 more
doaj +1 more source
Background: This study explored doctors’ understanding of ‘placebo’, mechanisms of action, perceptions about effectiveness and concerns about use in a Malaysian teaching hospital. Methods: A survey questionnaire.
Amanda Villiers Tuthill +5 more
doaj +1 more source
How often do general practitioners use placebos and non-specific interventions? Systematic review and meta-analysis of surveys. [PDF]
BACKGROUND:In a systematic review and meta-analysis we summarize the available evidence on how frequently general practitioners/family physicians (GPs) use pure placebos (e.g., placebo pills) and non-specific therapies (sometimes referred to as impure ...
Klaus Linde +6 more
doaj +1 more source
Background: In the LATITUDE study (ClinicalTrials.gov, NCT01715285), compared with placebos, abiraterone acetate plus prednisone (AAP) with androgen deprivation therapy (ADT) provided significant overall survival (OS) benefit in high-risk metastatic ...
Yosuke Koroki +3 more
doaj +1 more source
Placebo: Feeling Better, Getting Better, and the Problems of Mind and Body
Over its history, medicine has vacillated between acknowledging placebo effects as important and trying to overcome them. Placebos are controversial, in part, because they appear to challenge a biocentric view of the scientific basis of medical practice.
John F. Kihlstrom
doaj +1 more source
Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley +1 more source
Patients, pharmacists, and the placebo in France: From iatrogenic to ethical risks
Placebos have attracted widespread interest amongst anthropologists who have sought to explain the placebo dimension of medicines or healing rituals prescribed by health professionals or traditional healers by emphasizing aspects relating to symbolic ...
Sylvie Fainzang
doaj +1 more source

